The renin-angiotensin-aldosterone system (RAAS) – physiology and molecular mechanisms of functioning
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue
Abstract
Secretion of renin juxtaglomerular cells into bloodstream initiates activation of an enzymatic-hormonal cascade known as the RAAS (renin – angiotensin – aldosterone system). As a result, blood pressure is increased by the means several interrelated mechanisms. Mechanism of Zjednoczoaction of this system has been known for decades, but a few previously unknown components were recently added, such as ACE-2 and Ang(1-7), and their role often seems to be opposite to that of the conventional components. Local tissue systems also have important biological functions. They operate largely independently of the systemic activity, and their activity is observed primarily in the kidney, heart, in blood vessels, adrenal gland and nervous system. Angiotensin-2 (Ang-2), the main RAAS effector, has a wide scope of action, and thus abnormalities in its functioning have many consequences. Excessive activation is accompanied by chronic inflammation, as Ang-2 stimulates inflammatory mediators. As a result, degenerative processes and atherosclerosis are initiated. RAAS imbalance is associated with the most common diseases of civilization, such as cardio-vascular diseases, diabetes, kidney diseases, preeclampsia, osteoporosis and even neurodegenerative diseases. Many of these pathological processes are attributed to the excessive activation of tissue RA system. Therapeutic strategies based on inhibition of the RAAS are commonly used mainly in the treatment of hypertension and other cardiovascular disorders. The benefits of this class of drugs is primarily a decrease in blood pressure, but also the suppression of inflammatory processes and other pathological phenomena resulting from excessive activation of the RAAS. For that reason, some consider to use RAAS inhibitors in other diseases, e.g. Parkinson’s disease. Further studies give hope for the improvement of RAAS inhibitor therapy and the development of new therapeutic strategies
Authors and Affiliations
Monika Chaszczewska-Markowska, Maria Sagan, Katarzyna Bogunia-Kubik
Keywords
Related Articles
- EP ID EP220853
- DOI -
- Views 174
- Downloads 0
Regulacja melanogenezy: rola cAMP i MITF
W artykule przedstawiono przebieg melanogenezy oraz udział cAMP i czynnika transkrypcyjnego MITF w regulacji tego procesu. Produktami melanogenezy są eu- i/lub feomelaniny powstające w wyniku wieloetapowego procesu utlen...
Odd- and branched-chain fatty acids in milk fat – characteristic and health properties
This review analyzes the current state of knowledge on odd- and branched-chain fatty acids present in milk fat. Special attention is devoted to the characteristic, synthesis in ruminants, factors affecting their content...
Molekularne mechanizmy towarzyszące rozpoznawaniu patogenu przez receptory wrodzonej odporności
Odporność wrodzona jest pierwszą linią obrony przeciw patogenom. Struktury patogenów nazywane PAMPs (wzorce molekularne związane z patogenami) rozpoznawane są przez zewnątrz- i wewnątrzkomórkowe receptory PRRs, spośród k...
Wpływ polimorfizmu wirusa zapalenia wątroby typu B na przebieg choroby u osób przewlekle zakażonych
Hepatitis B virus (HBV) infection is one of the major human health problems worldwide. It is estimated that chronic HBV infection affects more than 350 million people globally. It is one of the leading causes of liver...
Drugs affecting the incretin system and renal glucose transport: do they meet the expectations of modern therapy of type 2 diabetes?
Agents introduced into therapy of type 2 diabetes in the last few years are still the subject of numerous clinical and experimental studies. Although many studies have been completed, we still do not know all aspects of...